Qepler | summits & conferences | 3rd Annual Highly Potent APIs Summit, Virtual Conference, 24-25 June 2021
Event Location:
Online Conference
Platform:
HOPIN
Date:
24 - 25 June 2021
Language:
English

Conference Overview

The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market. The highly toxic properties of HPAPIs, however, present manufacturing and handling challenges. Our meeting facilitates hands-on experience sharing with focus on early process development and scale up, occupational health regulations and safety standards, cross-contamination risk assessment and control, aseptic facilities and equipment maintenance and cleaning, outsourcing and technology transfer strategies.

The featured talks on:

  • EMA and GMP guidelines: novel requirements and considerations
  • Staying compliant with occupational HSE regulations and policies
  • Best practice containment strategies for highly potent APIs
  • Utilizing quality risk management practices to HPAPIs production
  • Handling and optimizing early process development
  • Understanding and developing a robust scale-up process
  • Handling highly potent compounds for ADC generation
  • Design and cleaning considerations for manufacturing facilities
  • Selecting the right CDMO partner for HPAPIs project
  • Successful technology transfer and outsourcing strategies

Meet our Speakers

Our Sponsors

PREVIOUS EVENT

SNAPSHOT OF ATTENDEES 2020

AbbVie - Acino Pharma AG - Affygility Solutions, LLC - Allergan plc - AMRI ITALY SRL - Andreas Flueckiger Consulting - Angelini Pharma S.p.A. - Bayer AG - Boehringer Ingelheim Pharma GmbH & Co. KG - F. Hoffmann-La Roche AG - Ferring International Center SA - Ferring Pharmaceuticals - Fresenius Kabi Austria GmbH - FUJIFILM Diosynth - GEA Process Engineering nv - Gedeon Richter Plc. - Hebeler Process Solutions LLC - Heraeus Deutschland GmbH & Co. KG - HPAPI Project Services Limited - ILC Dover - Lonza Pharma & Biotech - Merck & Cie - Merck Group - Merck Healthcare KGaA - Merck Performance Materials KGaA - Minakem High Potent - oncomed manufacturing a.s. - Pfizer CentreOne - Pharmacare Premium - Praevena AG - Quinta-Analytica - Raybow Pharmaceutical - SafeBridge Europe, Ltd. - Seqens R&D SERVICES - Servier - Synthon - Takeda - University of Oxford - Vanessa Research Magyarország Kft. - Vetter Pharma-Fertigung GmbH & Co. KG - Zentiva k.s. - Zhejiang Juli Electric Tools Co., Ltd and others.